14.11.2017 - 11:00

Congratulations to NCMM Director Kjetil Taskén on his new appointment

Director of Centre for Molecular Medicine Norway (NCMM), Professor Kjetil Taskén, has been appointed as the Head and Director of the Institute for Cancer Research at Oslo University Hospital. FIMM offers warm congratulations to Professor Taskén!

Founded in 1954, the Institute for Cancer Research at Oslo University Hospital plays a key role in the field of cancer research, both in Norway and internationally. The Institute has seven research departments and more than 320 employees.

Professor Taskén is the founding Director of NCMM, and until September 2017 also held the position of the Speaker for the Nordic EMBL Partnership for Molecular Medicine. He will start his new position on 1 January 2018. However, he will continue as NCMM Director until 30 June 2018 in a 40% position.

FIMM would like to thank Professor Taskén for his service as Speaker for the Nordic EMBL Partnership for Molecular Medicine and for his outstanding NCMM leadership in years past. The Institute looks forward to continuing the collaboration both with NCMM and Professor Taskén.

Read more: http://www.med.uio.no/ncmm/english/news-and-events/news/2017/ncmm-director-to-join-ouh.html

Last updated: 14.11.2017 - 12:48